Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Review Article

Future Perspective of Diabetic Animal Models

Author(s): Shashank Pandey and Magdalena C. Dvorakova*

Volume 20, Issue 1, 2020

Page: [25 - 38] Pages: 14

DOI: 10.2174/1871530319666190626143832

open access plus

Abstract

Objective: The need of today’s research is to develop successful and reliable diabetic animal models for understanding the disease susceptibility and pathogenesis. Enormous success of animal models had already been acclaimed for identifying key genetic and environmental factors like Idd loci and effects of microorganisms including the gut microbiota. Furthermore, animal models had also helped in identifying many therapeutic targets and strategies for immune-intervention. In spite of a quite success, we have acknowledged that many of the discovered immunotherapies are working on animals and did not have a significant impact on human. Number of animal models were developed in the past to accelerate drug discovery pipeline. However, due to poor initial screening and assessment on inequivalent animal models, the percentage of drug candidates who succeeded during clinical trials was very low. Therefore, it is essential to bridge this gap between pre-clinical research and clinical trial by validating the existing animal models for consistency.

Results and Conclusion: In this review, we have discussed and evaluated the significance of animal models on behalf of published data on PUBMED. Amongst the most popular diabetic animal models, we have selected six animal models (e.g. BioBreeding rat, “LEW IDDM rat”, “Nonobese Diabetic (NOD) mouse”, “STZ RAT”, “LEPR Mouse” and “Zucker Diabetic Fatty (ZDF) rat” and ranked them as per their published literature on PUBMED. Moreover, the vision and brief imagination for developing an advanced and robust diabetic model of 21st century was discussed with the theme of one miceone human concept including organs-on-chips.

Keywords: Animal model, diabetes mellitus, meta-analysis, humanized animal model, pathogens, immunotherapies.

Graphical Abstract

[1]
Ericsson, A.C.; Crim, M.J.; Franklin, C.L. A brief history of animal modeling. Mo. Med., 2013, 110(3), 201-205.
[PMID: 23829102]
[2]
Denayer, T.; Stöhr, T.; Van Roy, M. Animal models in translational medicine: Validation and prediction. New Horiz. Transl. Med., 2014, 2(1), 5-11.
[http://dx.doi.org/10.1016/j.nhtm.2014.08.001]
[3]
Balls, M. The wisdom of Russell and Burch. 3. Fidelity and discrimination. Altern. Lab. Anim., 2013, 41(1), 12-14.
[http://dx.doi.org/10.1177/026119291304100120] [PMID: 23614551]
[4]
Andes, D.; Craig, W.A. Animal model pharmacokinetics and pharmacodynamics: a critical review. Int. J. Antimicrob. Agents, 2002, 19(4), 261-268.
[http://dx.doi.org/10.1016/S0924-8579(02)00022-5] [PMID: 11978497]
[5]
Zhao, M.; Lepak, A.J.; Andes, D.R. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents. Bioorg. Med. Chem., 2016, 24(24), 6390-6400.
[http://dx.doi.org/10.1016/j.bmc.2016.11.008] [PMID: 27887963]
[6]
McGonigle, P.; Ruggeri, B. Animal models of human disease: challenges in enabling translation. Biochem. Pharmacol., 2014, 87(1), 162-171.
[http://dx.doi.org/10.1016/j.bcp.2013.08.006] [PMID: 23954708]
[7]
Vaddady, P.K.; Lee, R.E.; Meibohm, B. In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB. Future Med. Chem., 2010, 2(8), 1355-1369.
[http://dx.doi.org/10.4155/fmc.10.224] [PMID: 21359155]
[8]
Brochot, A.; Zamacona, M.; Stockis, A. Physiologically based pharmacokinetic/pharmacodynamic animal-to-man prediction of therapeutic dose in a model of epilepsy. Basic Clin. Pharmacol. Toxicol., 2010, 106(3), 256-262.
[http://dx.doi.org/10.1111/j.1742-7843.2009.00536.x] [PMID: 20102365]
[9]
Lodise, T.P.; Drusano, G.L. Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate. Clin. Infect. Dis., 2014, 58(Suppl. 1), S28-S34.
[http://dx.doi.org/10.1093/cid/cit615] [PMID: 24343829]
[10]
Ogurtsova, K.; da Rocha Fernandes, J.D.; Huang, Y.; Linnenkamp, U.; Guariguata, L.; Cho, N.H.; Cavan, D.; Shaw, J.E.; Makaroff, L.E. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract., 2017, 128, 40-50.
[http://dx.doi.org/10.1016/j.diabres.2017.03.024] [PMID: 28437734]
[11]
Rowley, W.R.; Bezold, C.; Arikan, Y.; Byrne, E.; Krohe, S. Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul. Health Manag., 2017, 20(1), 6-12.
[http://dx.doi.org/10.1089/pop.2015.0181] [PMID: 27124621]
[12]
Roden, M. [Diabetes mellitus: definition, classification and diagnosis Wien. Klin. Wochenschr., 2016, 128(Suppl. 2), S37-S40. [Diabetes mellitus: definition, classification and diagnosis]
[http://dx.doi.org/10.1007/s00508-015-0931-3] [PMID: 27052219]
[13]
Atkinson, M.A.; Eisenbarth, G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 2001, 358(9277), 221-229.
[http://dx.doi.org/10.1016/S0140-6736(01)05415-0] [PMID: 11476858]
[14]
Nyaga, D.M.; Vickers, M.H.; Jefferies, C.; Perry, J.K.; O’Sullivan, J.M. The genetic architecture of type 1 diabetes mellitus. Mol. Cell. Endocrinol., 2018, 477, 70-80.
[http://dx.doi.org/10.1016/j.mce.2018.06.002] [PMID: 29913182]
[15]
Redondo, M.J.; Fain, P.R.; Eisenbarth, G.S. Genetics of type 1A diabetes. Recent Prog. Horm. Res., 2001, 56, 69-89.
[http://dx.doi.org/10.1210/rp.56.1.69] [PMID: 11237226]
[16]
Kelly, M.A.; Mijovic, C.H.; Barnett, A.H. Genetics of type 1 diabetes. Best Pract. Res. Clin. Endocrinol. Metab., 2001, 15(3), 279-291.
[http://dx.doi.org/10.1053/beem.2001.0146] [PMID: 11554771]
[17]
Slavikova, J.; Mistrova, E.; Dvorakova, M.C. Pathophysiology of diabetic cardiomyopathy. Diabetologie Metabolismus Endokrinologie Vyziva, 2018, 21(1), 21-29.
[18]
DeFronzo, R.A.; Ferrannini, E.; Groop, L.; Henry, R.R.; Herman, W.H.; Holst, J.J.; Hu, F.B.; Kahn, C.R.; Raz, I.; Shulman, G.I.; Simonson, D.C.; Testa, M.A.; Weiss, R. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers, 2015, 1, 15019.
[http://dx.doi.org/10.1038/nrdp.2015.19] [PMID: 27189025]
[19]
Murai, Y.; Ohta, T.; Tadaki, H.; Miyajima, K.; Shinohara, M.; Fatchiyah, F.; Yamada, T. Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model. Med. Arh., 2017, 71(6), 380-384.
[http://dx.doi.org/10.5455/medarh.2017.71.380-384] [PMID: 29416195]
[20]
Al-Awar, A.; Kupai, K.; Veszelka, M.; Szűcs, G.; Attieh, Z.; Murlasits, Z.; Török, S.; Pósa, A.; Varga, C. Experimental Diabetes Mellitus in Different Animal Models. J. Diabetes Res., 2016. 20169051426
[http://dx.doi.org/10.1155/2016/9051426] [PMID: 27595114]
[21]
Srinivasan, K.; Ramarao, P. Animal models in type 2 diabetes research: an overview. Indian J. Med. Res., 2007, 125(3), 451-472.
[PMID: 17496368]
[22]
King, A.J. The use of animal models in diabetes research. Br. J. Pharmacol., 2012, 166(3), 877-894.
[http://dx.doi.org/10.1111/j.1476-5381.2012.01911.x] [PMID: 22352879]
[23]
Sasase, T.; Pezzolesi, M.G.; Yokoi, N.; Yamada, T.; Matsumoto, K. Animal models of diabetes and metabolic disease. J. Diabetes Res., 2013. 2013281928
[http://dx.doi.org/10.1155/2013/281928] [PMID: 23878821]
[24]
Mordes, J.P.; Bortell, R.; Blankenhorn, E.P.; Rossini, A.A.; Greiner, D.L. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J., 2004, 45(3), 278-291.
[http://dx.doi.org/10.1093/ilar.45.3.278] [PMID: 15229375]
[25]
Rees, D.A.; Alcolado, J.C. Animal models of diabetes mellitus. Diabet. Med., 2005, 22(4), 359-370.
[http://dx.doi.org/10.1111/j.1464-5491.2005.01499.x] [PMID: 15787657]
[26]
Wallis, R.H.; Wang, K.; Marandi, L.; Hsieh, E.; Ning, T.; Chao, G.Y.; Sarmiento, J.; Paterson, A.D.; Poussier, P. Type 1 diabetes in the BB rat: a polygenic disease. Diabetes, 2009, 58(4), 1007-1017.
[http://dx.doi.org/10.2337/db08-1215] [PMID: 19168599]
[27]
Holmberg, R.; Refai, E.; Höög, A.; Crooke, R.M.; Graham, M.; Olivecrona, G.; Berggren, P.O.; Juntti-Berggren, L. Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proc. Natl. Acad. Sci. USA, 2011, 108(26), 10685-10689.
[http://dx.doi.org/10.1073/pnas.1019553108] [PMID: 21670290]
[28]
Hartoft-Nielsen, M.L.; Rasmussen, A.K.; Bock, T.; Feldt-Rasmussen, U.; Kaas, A.; Buschard, K. Iodine and tri-iodo-thyronine reduce the incidence of type 1 diabetes mellitus in the autoimmune prone BB rats. Autoimmunity, 2009, 42(2), 131-138.
[http://dx.doi.org/10.1080/08916930802438774] [PMID: 19021014]
[29]
Zhang, W.; Kamiya, H.; Ekberg, K.; Wahren, J.; Sima, A.A. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. Diabetes Metab. Res. Rev., 2007, 23(1), 63-70.
[http://dx.doi.org/10.1002/dmrr.672] [PMID: 16845685]
[30]
Jörns, A.; Günther, A.; Hedrich, H.J.; Wedekind, D.; Tiedge, M.; Lenzen, S. Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes, 2005, 54(7), 2041-2052.
[http://dx.doi.org/10.2337/diabetes.54.7.2041] [PMID: 15983205]
[31]
Lenzen, S.; Tiedge, M.; Elsner, M.; Lortz, S.; Weiss, H.; Jörns, A.; Klöppel, G.; Wedekind, D.; Prokop, C.M.; Hedrich, H.J. The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus. Diabetologia, 2001, 44(9), 1189-1196.
[http://dx.doi.org/10.1007/s001250100625] [PMID: 11596676]
[32]
Mathews, C.E. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes. Pediatr. Diabetes, 2005, 6(3), 165-177.
[http://dx.doi.org/10.1111/j.1399-543X.2005.00123.x] [PMID: 16109074]
[33]
Jörns, A.; Rath, K.J.; Terbish, T.; Arndt, T.; Meyer Zu Vilsendorf, A.; Wedekind, D.; Hedrich, H.J.; Lenzen, S. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation. Endocrinology, 2010, 151(8), 3555-3565.
[http://dx.doi.org/10.1210/en.2010-0202] [PMID: 20501676]
[34]
Arndt, T.; Wedekind, D.; Weiss, H.; Tiedge, M.; Lenzen, S.; Hedrich, H.J.; Jörns, A. Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes. Diabetologia, 2009, 52(7), 1381-1390.
[http://dx.doi.org/10.1007/s00125-009-1348-1] [PMID: 19367386]
[35]
Jörns, A.; Kubat, B.; Tiedge, M.; Wedekind, D.; Hedrich, H.J.; Klöppel, G.; Lenzen, S. Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm- iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus. Virchows Arch., 2004, 444(2), 183-189.
[http://dx.doi.org/10.1007/s00428-003-0956-2] [PMID: 14735361]
[36]
Peschke, E.; Hofmann, K.; Bähr, I.; Streck, S.; Albrecht, E.; Wedekind, D.; Mühlbauer, E. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus). Diabetologia, 2011, 54(7), 1831-1840.
[http://dx.doi.org/10.1007/s00125-011-2138-0] [PMID: 21491159]
[37]
Yang, Z.; Chen, M.; Fialkow, L.B.; Ellett, J.D.; Wu, R.; Brinkmann, V.; Nadler, J.L.; Lynch, K.R. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice. Clin. Immunol., 2003, 107(1), 30-35.
[http://dx.doi.org/10.1016/S1521-6616(02)00054-2] [PMID: 12738247]
[38]
Maki, T.; Gottschalk, R.; Ogawa, N.; Monaco, A.P. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. Transplantation, 2005, 79(9), 1051-1055.
[http://dx.doi.org/10.1097/01.TP.0000161220.87548.EE] [PMID: 15880042]
[39]
Hanafusa, T.; Miyagawa, J.; Nakajima, H.; Tomita, K.; Kuwajima, M.; Matsuzawa, Y.; Tarui, S. The NOD mouse. Diabetes Res. Clin. Pract., (24), S307-S311.1994.
[http://dx.doi.org/10.1016/0168-8227(94)90267-4]
[40]
Yoon, J.W.; Jun, H.S. Viruses in type 1 diabetes: brief review. ILAR J., 2004, 45(3), 343-348.
[http://dx.doi.org/10.1093/ilar.45.3.343] [PMID: 15229381]
[41]
Jansen, A.; Homo-Delarche, F.; Hooijkaas, H.; Leenen, P.J.; Dardenne, M.; Drexhage, H.A. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes, 1994, 43(5), 667-675.
[http://dx.doi.org/10.2337/diab.43.5.667] [PMID: 8168644]
[42]
Bouma, G.; Coppens, J.M.; Mourits, S.; Nikolic, T.; Sozzani, S.; Drexhage, H.A.; Versnel, M.A. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur. J. Immunol., 2005, 35(8), 2386-2396.
[http://dx.doi.org/10.1002/eji.200526251] [PMID: 16047341]
[43]
Diana, J.; Simoni, Y.; Furio, L.; Beaudoin, L.; Agerberth, B.; Barrat, F.; Lehuen, A. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med., 2013, 19(1), 65-73.
[http://dx.doi.org/10.1038/nm.3042] [PMID: 23242473]
[44]
Willcox, A.; Richardson, S.J.; Bone, A.J.; Foulis, A.K.; Morgan, N.G. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol., 2009, 155(2), 173-181.
[http://dx.doi.org/10.1111/j.1365-2249.2008.03860.x] [PMID: 19128359]
[45]
Miyazaki, A.; Hanafusa, T.; Yamada, K.; Miyagawa, J.; Fujino-Kurihara, H.; Nakajima, H.; Nonaka, K.; Tarui, S. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin. Exp. Immunol., 1985, 60(3), 622-630.
[PMID: 3160515]
[46]
Pearson, J.A.; Wong, F.S.; Wen, L. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes. J. Autoimmun., 2016, 66, 76-88.
[http://dx.doi.org/10.1016/j.jaut.2015.08.019] [PMID: 26403950]
[47]
Noble, J.A.; Erlich, H.A. Genetics of type 1 diabetes. Cold Spring Harb. Perspect. Med., 2012, 2(1)a007732
[http://dx.doi.org/10.1101/cshperspect.a007732] [PMID: 22315720]
[48]
Chen, Y.G.; Mathews, C.E.; Driver, J.P. The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future. Front. Endocrinol. (Lausanne), 2018, 9, 51.
[http://dx.doi.org/10.3389/fendo.2018.00051] [PMID: 29527189]
[49]
Todd, J.A.; Wicker, L.S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity, 2001, 15(3), 387-395.
[http://dx.doi.org/10.1016/S1074-7613(01)00202-3] [PMID: 11567629]
[50]
von Herrath, M.; Filippi, C.; Coppieters, K. How viral infections enhance or prevent type 1 diabetes-from mouse to man. J. Med. Virol., 2011, 83(9), 1672.
[http://dx.doi.org/10.1002/jmv.22063] [PMID: 21739461]
[51]
Yang, Y.; Santamaria, P. Lessons on autoimmune diabetes from animal models. Clin. Sci. (Lond.), 2006, 110(6), 627-639.
[http://dx.doi.org/10.1042/CS20050330] [PMID: 16689681]
[52]
Mathews, C.E.; Langley, S.H.; Leiter, E.H. New mouse model to study islet transplantation in insulin-dependent diabetes mellitus. Transplantation, 2002, 73(8), 1333-1336.
[http://dx.doi.org/10.1097/00007890-200204270-00024] [PMID: 11981430]
[53]
Drel, V.R.; Pacher, P.; Stavniichuk, R.; Xu, W.; Zhang, J.; Kuchmerovska, T.M.; Slusher, B.; Obrosova, I.G. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice. Int. J. Mol. Med., 2011, 28(4), 629-635.
[PMID: 21617845]
[54]
Zhou, C.; Pridgen, B.; King, N.; Xu, J.; Breslow, J.L. Hyperglycemic Ins2AkitaLdlr/ mice show severely elevated lipid levels and increased atherosclerosis: a model of type 1 diabetic macrovascular disease. J. Lipid Res., 2011, 52(8), 1483-1493.
[http://dx.doi.org/10.1194/jlr.M014092] [PMID: 21606463]
[55]
Gurley, S.B.; Clare, S.E.; Snow, K.P.; Hu, A.; Meyer, T.W.; Coffman, T.M. Impact of genetic background on nephropathy in diabetic mice. Am. J. Physiol. Renal Physiol., 2006, 290(1), F214-F222.
[http://dx.doi.org/10.1152/ajprenal.00204.2005] [PMID: 16118394]
[56]
Tyrberg, B.; Andersson, A.; Borg, L.A. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan. Gen. Comp. Endocrinol., 2001, 122(3), 238-251.
[http://dx.doi.org/10.1006/gcen.2001.7638] [PMID: 11356036]
[57]
Dufrane, D.; van Steenberghe, M.; Guiot, Y.; Goebbels, R.M.; Saliez, A.; Gianello, P. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation, 2006, 81(1), 36-45.
[http://dx.doi.org/10.1097/01.tp.0000189712.74495.82] [PMID: 16421474]
[58]
Eizirik, D.L.; Pipeleers, D.G.; Ling, Z.; Welsh, N.; Hellerström, C.; Andersson, A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Natl. Acad. Sci. USA, 1994, 91(20), 9253-9256.
[http://dx.doi.org/10.1073/pnas.91.20.9253] [PMID: 7937750]
[59]
Lenzen, S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 2008, 51(2), 216-226.
[http://dx.doi.org/10.1007/s00125-007-0886-7] [PMID: 18087688]
[60]
Wise, M.H.; Gordon, C.; Johnson, R.W. Intraportal autotransplantation of cryopreserved porcine islets of Langerhans. Cryobiology, 1985, 22(4), 359-366.
[http://dx.doi.org/10.1016/0011-2240(85)90183-X] [PMID: 3161702]
[61]
He, S.; Chen, Y.; Wei, L.; Jin, X.; Zeng, L.; Ren, Y.; Zhang, J.; Wang, L.; Li, H.; Lu, Y.; Cheng, J. Treatment and risk factor analysis of hypoglycemia in diabetic rhesus monkeys. Exp. Biol. Med. (Maywood), 2011, 236(2), 212-218.
[http://dx.doi.org/10.1258/ebm.2010.010208] [PMID: 21321318]
[62]
Wei, L.; Lu, Y.; He, S.; Jin, X.; Zeng, L.; Zhang, S.; Chen, Y.; Tian, B.; Mai, G.; Yang, G.; Zhang, J.; Wang, L.; Li, H.; Markmann, J.F.; Cheng, J.; Deng, S. Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin. Biochem. Biophys. Res. Commun., 2011, 412(2), 373-378.
[http://dx.doi.org/10.1016/j.bbrc.2011.07.105] [PMID: 21821007]
[63]
Moon, C.H.; Jung, Y.S.; Lee, S.H.; Baik, E.J. Protein kinase C inhibitors abolish the increased resistance of diabetic rat heart to ischemia-reperfusion injury. Jpn. J. Physiol., 1999, 49(5), 409-415.
[http://dx.doi.org/10.2170/jjphysiol.49.409] [PMID: 10603424]
[64]
Chen, H.; Shen, W.L.; Wang, X.H.; Chen, H.Z.; Gu, J.Z.; Fu, J.; Ni, Y.F.; Gao, P.J.; Zhu, D.L.; Higashino, H. Paradoxically enhanced heart tolerance to ischaemia in type 1 diabetes and role of increased osmolarity. Clin. Exp. Pharmacol. Physiol., 2006, 33(10), 910-916.
[http://dx.doi.org/10.1111/j.1440-1681.2006.04463.x] [PMID: 17002667]
[65]
Ravingerova, T.; Matejikova, J.; Pancza, D.; Kolar, F. Reduced susceptibility to ischemia-induced arrhythmias in the preconditioned rat heart is independent of PI3-kinase/Akt. Physiol. Res., 2009, 58(3), 443-447.
[PMID: 19627174]
[66]
Chen, H.; Charlat, O.; Tartaglia, L.A.; Woolf, E.A.; Weng, X.; Ellis, S.J.; Lakey, N.D.; Culpepper, J.; Moore, K.J.; Breitbart, R.E.; Duyk, G.M.; Tepper, R.I.; Morgenstern, J.P. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell, 1996, 84(3), 491-495.
[http://dx.doi.org/10.1016/S0092-8674(00)81294-5] [PMID: 8608603]
[67]
Gault, V.A.; Kerr, B.D.; Harriott, P.; Flatt, P.R. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Clin. Sci. (Lond.), 2011, 121(3), 107-117.
[http://dx.doi.org/10.1042/CS20110006] [PMID: 21332446]
[68]
Yoshida, S.; Tanaka, H.; Oshima, H.; Yamazaki, T.; Yonetoku, Y.; Ohishi, T.; Matsui, T.; Shibasaki, M. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Biochem. Biophys. Res. Commun., 2010, 400(4), 745-751.
[http://dx.doi.org/10.1016/j.bbrc.2010.08.141] [PMID: 20816753]
[69]
Park, J.S.; Rhee, S.D.; Kang, N.S.; Jung, W.H.; Kim, H.Y.; Kim, J.H.; Kang, S.K.; Cheon, H.G.; Ahn, J.H.; Kim, K.Y. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344). Biochem. Pharmacol., 2011, 81(8), 1028-1035.
[http://dx.doi.org/10.1016/j.bcp.2011.01.020] [PMID: 21315688]
[70]
Lindström, P. The physiology of obese-hyperglycemic mice. [ob/ob mice] ScientificWorldJournal, 2007, 7, 666-685. [ob/ob mice]
[http://dx.doi.org/ 10.1100/tsw.2007.117] [PMID: 17619751]
[71]
Chehab, F.F.; Lim, M.E.; Lu, R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet., 1996, 12(3), 318-320.
[http://dx.doi.org/10.1038/ng0396-318] [PMID: 8589726]
[72]
Bock, T.; Pakkenberg, B.; Buschard, K. Increased islet volume but unchanged islet number in ob/ob mice. Diabetes, 2003, 52(7), 1716-1722.
[http://dx.doi.org/10.2337/diabetes.52.7.1716] [PMID: 12829638]
[73]
Lavine, R.L.; Voyles, N.; Perrino, P.V.; Recant, L. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse. Am. J. Physiol., 1977, 233(2), E86-E90.
[PMID: 329686]
[74]
Coleman, D.L. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia, 1978, 14(3), 141-148.
[http://dx.doi.org/10.1007/BF00429772] [PMID: 350680]
[75]
Asensio, C.; Cettour-Rose, P.; Theander-Carrillo, C.; Rohner-Jeanrenaud, F.; Muzzin, P. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology, 2004, 145(5), 2206-2213.
[http://dx.doi.org/10.1210/en.2003-1679] [PMID: 14962997]
[76]
Zhang, B.; Salituro, G.; Szalkowski, D.; Li, Z.; Zhang, Y.; Royo, I.; Vilella, D.; Díez, M.T.; Pelaez, F.; Ruby, C.; Kendall, R.L.; Mao, X.; Griffin, P.; Calaycay, J.; Zierath, J.R.; Heck, J.V.; Smith, R.G.; Moller, D.E. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science, 1999, 284(5416), 974-977.
[http://dx.doi.org/10.1126/science.284.5416.974] [PMID: 10320380]
[77]
Chakrabarti, R.; Vikramadithyan, R.K.; Misra, P.; Hiriyan, J.; Raichur, S.; Damarla, R.K.; Gershome, C.; Suresh, J.; Rajagopalan, R. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models. Br. J. Pharmacol., 2003, 140(3), 527-537.
[http://dx.doi.org/10.1038/sj.bjp.0705463] [PMID: 12970088]
[78]
Hummel, K.P.; Dickie, M.M.; Coleman, D.L. Diabetes, a new mutation in the mouse. Science, 1966, 153(3740), 1127-1128.
[http://dx.doi.org/10.1126/science.153.3740.1127] [PMID: 5918576]
[79]
Phillips, M.S.; Liu, Q.; Hammond, H.A.; Dugan, V.; Hey, P.J.; Caskey, C.J.; Hess, J.F. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet., 1996, 13(1), 18-19.
[http://dx.doi.org/10.1038/ng0596-18] [PMID: 8673096]
[80]
Tokuyama, Y.; Sturis, J.; DePaoli, A.M.; Takeda, J.; Stoffel, M.; Tang, J.; Sun, X.; Polonsky, K.S.; Bell, G.I. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes, 1995, 44(12), 1447-1457.
[http://dx.doi.org/10.2337/diab.44.12.1447] [PMID: 7589853]
[81]
Lee, Y.; Hirose, H.; Zhou, Y.T.; Esser, V.; McGarry, J.D.; Unger, R.H. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes, 1997, 46(3), 408-413.
[http://dx.doi.org/10.2337/diab.46.3.408] [PMID: 9032096]
[82]
Shimabukuro, M.; Zhou, Y.T.; Levi, M.; Unger, R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. USA, 1998, 95(5), 2498-2502.
[http://dx.doi.org/10.1073/pnas.95.5.2498] [PMID: 9482914]
[83]
Shimabukuro, M.; Higa, M.; Zhou, Y.T.; Wang, M.Y.; Newgard, C.B.; Unger, R.H. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem., 1998, 273(49), 32487-32490.
[http://dx.doi.org/10.1074/jbc.273.49.32487] [PMID: 9829981]
[84]
Hemmes, R.B.; Schoch, R. High dosage testosterone propionate induces copulatory behavior in the obese male Zucker rat. Physiol. Behav., 1988, 43(3), 321-324.
[http://dx.doi.org/10.1016/0031-9384(88)90195-3] [PMID: 3174844]
[85]
Shibata, T.; Takeuchi, S.; Yokota, S.; Kakimoto, K.; Yonemori, F.; Wakitani, K. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br. J. Pharmacol., 2000, 130(3), 495-504.
[http://dx.doi.org/10.1038/sj.bjp.0703328] [PMID: 10821776]
[86]
Clohessy, J.G.; Pandolfi, P.P. Mouse hospital and co-clinical trial project--from bench to bedside. Nat. Rev. Clin. Oncol., 2015, 12(8), 491-498.
[http://dx.doi.org/10.1038/nrclinonc.2015.62] [PMID: 25895610]
[87]
Clohessy, J.G.; Pandolfi, P.P. The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care. Front. Oncol., 2018, 8, 340.
[http://dx.doi.org/10.3389/fonc.2018.00340] [PMID: 30211119]
[88]
Yang, F.; Stewart, M.; Ye, J.; DeMets, D. Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements. Diabetes Metab. Syndr. Obes., 2015, 8, 315-325.
[http://dx.doi.org/10.2147/DMSO.S84005] [PMID: 26229496]
[89]
Brass, E.P. The Food and Drug Administration and the Future of Drug Development for the Treatment of Diabetes. Diabetes Spectr., 2014, 27(2), 75-77.
[http://dx.doi.org/10.2337/diaspect.27.2.75] [PMID: 26246760]
[90]
Smith, R.J.; Goldfine, A.B.; Hiatt, W.R. Evaluating the Cardiovascular Safety of New Medications for Type 2 Diabetes: Time to Reassess? Diabetes Care, 2016, 39(5), 738-742.
[http://dx.doi.org/10.2337/dc15-2237] [PMID: 27208377]
[91]
Garcia-Verdugo, R.; Erbach, M.; Schnell, O. Need for Outcome Scenario Analysis of Clinical Trials in Diabetes. J. Diabetes Sci. Technol., 2017, 11(2), 327-334.
[http://dx.doi.org/10.1177/1932296816670925] [PMID: 27707913]
[92]
Derscheid, R.J.; Ackermann, M.R. Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses, 2012, 4(10), 2359-2378.
[http://dx.doi.org/10.3390/v4102359] [PMID: 23202468]
[93]
Sams-Dodd, F. Strategies to optimize the validity of disease models in the drug discovery process. Drug Discov. Today, 2006, 11(7-8), 355-363.
[http://dx.doi.org/10.1016/j.drudis.2006.02.005] [PMID: 16580978]
[94]
Cavagnaro, J.; Silva Lima, B. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products. Eur. J. Pharmacol., 2015, 759, 51-62.
[http://dx.doi.org/10.1016/j.ejphar.2015.03.048] [PMID: 25814257]
[95]
Pinger, C.W.; Entwistle, K.E.; Bell, T.M.; Liu, Y.; Spence, D.M. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? Mol. Biosyst., 2017, 13(8), 1432-1437.
[http://dx.doi.org/10.1039/C7MB00199A] [PMID: 28685788]
[96]
Nissen, S.E.; Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med., 2007, 356(24), 2457-2471.
[http://dx.doi.org/10.1056/NEJMoa072761] [PMID: 17517853]
[97]
Cheng, D.; Gao, H.; Li, W. Long-term risk of rosiglitazone on cardiovascular events - a systematic review and meta-analysis. Endokrynol. Pol., 2018, 69(4), 381-394.
[PMID: 29952413]
[98]
Singh, S.; Loke, Y.K.; Furberg, C.D. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA, 2007, 298(10), 1189-1195.
[http://dx.doi.org/10.1001/jama.298.10.1189] [PMID: 17848653]
[99]
Blind, E.; Dunder, K.; de Graeff, P.A.; Abadie, E. Rosiglitazone: a European regulatory perspective. Diabetologia, 2011, 54(2), 213-218.
[http://dx.doi.org/10.1007/s00125-010-1992-5] [PMID: 21153629]
[100]
Cummings, J.L.; Morstorf, T.; Zhong, K. Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res. Ther., 2014, 6(4), 37.
[http://dx.doi.org/10.1186/alzrt269] [PMID: 25024750]
[101]
van der Worp, H.B.; Howells, D.W.; Sena, E.S.; Porritt, M.J.; Rewell, S.; O’Collins, V.; Macleod, M.R. Can animal models of disease reliably inform human studies? PLoS Med., 2010, 7(3)e1000245
[http://dx.doi.org/10.1371/journal.pmed.1000245] [PMID: 20361020]
[102]
Tyagi, P.; Pechenov, S.; Anand Subramony, J. Oral peptide delivery: Translational challenges due to physiological effects. J. Control. Release, 2018, 287, 167-176.
[http://dx.doi.org/10.1016/j.jconrel.2018.08.032] [PMID: 30145135]
[103]
Hooper, S.B.; Te Pas, A.B.; Polglase, G.R.; Wyckoff, M. Animal models in neonatal resuscitation research: What can they teach us? Semin. Fetal Neonatal Med., 2018, 23(5), 300-305.
[http://dx.doi.org/10.1016/j.siny.2018.07.002] [PMID: 30001819]
[104]
Koch, J.C.; Tatenhorst, L.; Roser, A.E.; Saal, K.A.; Tönges, L.; Lingor, P. ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol. Ther., 2018, 189, 1-21.
[http://dx.doi.org/10.1016/j.pharmthera.2018.03.008] [PMID: 29621594]
[105]
Eicher, A.K.; Berns, H.M.; Wells, J.M. Translating Developmental Principles to Generate Human Gastric Organoids. Cell. Mol. Gastroenterol. Hepatol., 2018, 5(3), 353-363.
[http://dx.doi.org/10.1016/j.jcmgh.2017.12.014] [PMID: 29552623]
[106]
Kenney, L.L.; Shultz, L.D.; Greiner, D.L.; Brehm, M.A. Humanized Mouse Models for Transplant Immunology. Am. J. Transplant., 2016, 16(2), 389-397.
[http://dx.doi.org/10.1111/ajt.13520] [PMID: 26588186]
[107]
Wege, A.K. Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy. BioDrugs, 2018, 32(3), 245-266.
[http://dx.doi.org/10.1007/s40259-018-0275-4] [PMID: 29589229]
[108]
Ito, R.; Takahashi, T.; Katano, I.; Ito, M. Current advances in humanized mouse models. Cell. Mol. Immunol., 2012, 9(3), 208-214.
[http://dx.doi.org/10.1038/cmi.2012.2] [PMID: 22327211]
[109]
Abaci, H.E.; Shuler, M.L. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling. Integr. Biol., 2015, 7(4), 383-391.
[http://dx.doi.org/10.1039/C4IB00292J] [PMID: 25739725]
[110]
Brown, J.A.; Codreanu, S.G.; Shi, M.; Sherrod, S.D.; Markov, D.A.; Neely, M.D.; Britt, C.M.; Hoilett, O.S.; Reiserer, R.S.; Samson, P.C.; McCawley, L.J.; Webb, D.J.; Bowman, A.B.; McLean, J.A.; Wikswo, J.P. Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit. J. Neuroinflammation, 2016, 13(1), 306.
[http://dx.doi.org/10.1186/s12974-016-0760-y] [PMID: 27955696]
[111]
Dodson, K.H.; Echevarria, F.D.; Li, D.; Sappington, R.M.; Edd, J.F. Retina-on-a-chip: a microfluidic platform for point access signaling studies. Biomed. Microdevices, 2015, 17(6), 114.
[http://dx.doi.org/10.1007/s10544-015-0019-x] [PMID: 26559199]
[112]
Dorval, T.; Chanrion, B.; Cattin, M.E.; Stephan, J.P. Filling the drug discovery gap: is high-content screening the missing link? Curr. Opin. Pharmacol., 2018, 42, 40-45.
[http://dx.doi.org/10.1016/j.coph.2018.07.002] [PMID: 30032033]
[113]
Hachey, S.J.; Hughes, C.C.W. Applications of tumor chip technology. Lab Chip, 2018, 18(19), 2893-2912.
[http://dx.doi.org/10.1039/C8LC00330K] [PMID: 30156248]
[114]
Irimia, D.; Wang, X. Inflammation-on-a-Chip: Probing the Immune System Ex Vivo. Trends Biotechnol., 2018, 36(9), 923-937.
[http://dx.doi.org/10.1016/j.tibtech.2018.03.011] [PMID: 29728272]
[115]
Kodzius, R.; Schulze, F.; Gao, X.; Schneider, M.R. Organ-on-Chip Technology: Current State and Future Developments. Genes (Basel), 2017, 8(10)E266
[http://dx.doi.org/10.3390/genes8100266] [PMID: 29019963]
[116]
Mandenius, C.F. Conceptual Design of Micro-Bioreactors and Organ-on-Chips for Studies of Cell Cultures. Bioengineering (Basel), 2018, 5(3)E56
[http://dx.doi.org/10.3390/bioengineering5030056] [PMID: 30029542]
[117]
Miranda, C.C.; Fernandes, T.G.; Diogo, M.M.; Cabral, J.M.S. Towards Multi-Organoid Systems for Drug Screening Applications. Bioengineering (Basel), 2018, 5(3)E49
[http://dx.doi.org/10.3390/bioengineering5030049] [PMID: 29933623]
[118]
Nikolic, M.; Sustersic, T.; Filipovic, N. In vitro Models and On-Chip Systems: Biomaterial Interaction Studies With Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines. Front. Bioeng. Biotechnol., 2018, 6, 120.
[http://dx.doi.org/10.3389/fbioe.2018.00120] [PMID: 30234106]
[119]
Rothbauer, M.; Rosser, J.M.; Zirath, H.; Ertl, P. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models. Curr. Opin. Biotechnol., 2019, 55, 81-86.
[http://dx.doi.org/10.1016/j.copbio.2018.08.009] [PMID: 30189349]
[120]
Wikswo, J.P.; Block, F.E., III; Cliffel, D.E.; Goodwin, C.R.; Marasco, C.C.; Markov, D.A.; McLean, D.L.; McLean, J.A.; McKenzie, J.R.; Reiserer, R.S.; Samson, P.C.; Schaffer, D.K.; Seale, K.T.; Sherrod, S.D. Engineering challenges for instrumenting and controlling integrated organ-on-chip systems. IEEE Trans. Biomed. Eng., 2013, 60(3), 682-690.
[http://dx.doi.org/10.1109/TBME.2013.2244891] [PMID: 23380852]
[121]
Wikswo, J.P.; Curtis, E.L.; Eagleton, Z.E.; Evans, B.C.; Kole, A.; Hofmeister, L.H.; Matloff, W.J. Scaling and systems biology for integrating multiple organs-on-a-chip. Lab Chip, 2013, 13(18), 3496-3511.
[http://dx.doi.org/10.1039/c3lc50243k] [PMID: 23828456]
[122]
Wikswo, J.P. Looking to the future of organs-on-chips: interview with Professor John Wikswo. Future Sci. OA, 2017, 3(2)FSO163
[http://dx.doi.org/10.4155/fsoa-2016-0085] [PMID: 28670462]
[123]
Wnorowski, A.; Yang, H.; Wu, J.C. Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models. dv. Drug Deliv. Rev., 2018, S0169-409X(18), 30132-7.
[http://dx.doi.org/10.1016/j.addr.2018.06.001] [PMID: 29885330]
[124]
Kersten, K.; de Visser, K.E.; van Miltenburg, M.H.; Jonkers, J. Genetically engineered mouse models in oncology research and cancer medicine. EMBO Mol. Med., 2017, 9(2), 137-153.
[http://dx.doi.org/10.15252/emmm.201606857] [PMID: 28028012]
[125]
Uhl, E.W.; Warner, N.J. Mouse Models as Predictors of Human Responses: Evolutionary Medicine. Curr. Pathobiol. Rep., 2015, 3(3), 219-223.
[http://dx.doi.org/10.1007/s40139-015-0086-y] [PMID: 26246962]
[126]
Luce, S.; Guinoiseau, S.; Gadault, A.; Letourneur, F.; Blondeau, B.; Nitschke, P.; Pasmant, E.; Vidaud, M.; Lemonnier, F.; Boitard, C. Humanized Mouse Model to Study Type 1 Diabetes. Diabetes, 2018, 67(9), 1816-1829.
[http://dx.doi.org/10.2337/db18-0202] [PMID: 29967002]
[127]
Walsh, N.C.; Kenney, L.L.; Jangalwe, S.; Aryee, K.E.; Greiner, D.L.; Brehm, M.A.; Shultz, L.D. Humanized Mouse Models of Clinical Disease. Annu. Rev. Pathol., 2017, 12, 187-215.
[http://dx.doi.org/10.1146/annurev-pathol-052016-100332] [PMID: 27959627]
[128]
Puca, L.; Bareja, R.; Prandi, D.; Shaw, R.; Benelli, M.; Karthaus, W.R.; Hess, J.; Sigouros, M.; Donoghue, A.; Kossai, M.; Gao, D.; Cyrta, J.; Sailer, V.; Vosoughi, A.; Pauli, C.; Churakova, Y.; Cheung, C.; Deonarine, L.D.; McNary, T.J.; Rosati, R.; Tagawa, S.T.; Nanus, D.M.; Mosquera, J.M.; Sawyers, C.L.; Chen, Y.; Inghirami, G.; Rao, R.A.; Grandori, C.; Elemento, O.; Sboner, A.; Demichelis, F.; Rubin, M.A.; Beltran, H. Patient derived organoids to model rare prostate cancer phenotypes. Nat. Commun., 2018, 9(1), 2404.
[http://dx.doi.org/10.1038/s41467-018-04495-z] [PMID: 29921838]
[129]
Ibarrola-Villava, M.; Cervantes, A.; Bardelli, A. Preclinical models for precision oncology. Biochim. Biophys. Acta Rev. Cancer, 2018, 1870(2), 239-246.
[http://dx.doi.org/10.1016/j.bbcan.2018.06.004] [PMID: 29959990]
[130]
Garralda, E.; Paz, K.; López-Casas, P.P.; Jones, S.; Katz, A.; Kann, L.M.; López-Rios, F.; Sarno, F.; Al-Shahrour, F.; Vasquez, D.; Bruckheimer, E.; Angiuoli, S.V.; Calles, A.; Diaz, L.A.; Velculescu, V.E.; Valencia, A.; Sidransky, D.; Hidalgo, M. Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment. Clin. Cancer Res., 2014, 20(9), 2476-2484.
[http://dx.doi.org/10.1158/1078-0432.CCR-13-3047] [PMID: 24634382]
[131]
Malaney, P.; Nicosia, S.V.; Davé, V. One mouse, one patient paradigm: New avatars of personalized cancer therapy. Cancer Lett., 2014, 344(1), 1-12.
[http://dx.doi.org/10.1016/j.canlet.2013.10.010] [PMID: 24157811]
[132]
Zayed, A.A.; Mandrekar, S.J.; Haluska, P. Molecular and clinical implementations of ovarian cancer mouse avatar models. Linchuang Zhongliuxue Zazhi, 2015, 4(3), 30.
[PMID: 26408297]
[133]
Saadat, V.; Tsugita, R. Device for sensing parameters of a hollow body organ. U.S. Patent 6,939,313 B2. 2005.
[134]
Wikswo, J.P.; Samson, P.C.; Emmanuel, F.; Reiserer, R.S.; Parker, K.K.; McLean, J.A.; McCawley, L.J.; Markov, D.; Levner, D.; Ingber, D.E.; Hamilton, G.A.; Goss, J.A.; Cunningham, R.; Cliffel, D.E.; McKenzie, R.J.; Bahinski, A.; Hinojosa, C.D. Integrated human organ-on-chip microphysiological systems. U.S. Patent 9,725,687 B2. 2017.
[135]
Gonda, S.R.; Chang, R.C.; Starly, B.; Culbertson, C.; Holtorf, H.L.; Sun, W.; Leslie, J. Micro-organ device. U.S. Patent 2013/0109594 A1 2013.
[136]
Gatenholm, P. Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering. Patent 8,691.974 B2. 2014.
[137]
Ingber, D.E.; Parker, K.K.; Hamilton, G.A.; Bahinski, A. Organ chips and uses thereof. U.S. Patent 10, 087, 422 B2. 2018.
[138]
Andreassen, S.; Falck, B.; Olesen, K.G. Diagnostic function of the microhuman prototype of the expert system--MUNIN. Electroencephalogr. Clin. Neurophysiol., 1992, 85(2), 143-157.
[http://dx.doi.org/10.1016/0168-5597(92)90080-U] [PMID: 1373367]

© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version299msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[02:56:06] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[02:56:06] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[02:56:06] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (88.92ms)time
  • Application (210ms)time
  • 1 x Application (70.29%)
    210ms
    1 x Booting (29.71%)
    88.92ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    32 statements were executed, 4 of which were duplicates, 28 unique. Show only duplicated144ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('51359721','',1,1739847366,1739847366) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1739847366
      890μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('51359721','/article/99232',1,1739847366,1739847366)
      150μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) limit 1
      12.95msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 51359721
      • 1: 51359721
      • 2: 51359721
      • 3: 51359721
      • 4: 51359721
      • 5: 51359721
      • 6: 51359721
      • 7: 51359721
      • 8: 51359721
      • 9: 51359721
      • 10: 51359721
      • 11: 51359721
      • 12: 51359721
      • 13: 51359721
      • 14: 51359721
      • 15: 51359721
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=99232
      660μsalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 59 limit 1
      750μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 59
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=59) and sj.journal_id!=59 group by `j`.`nid`) as `aggregate_table`
      1.32msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=59) and sj.journal_id!=59 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      1.04msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=59) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      4.7msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=59) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      3.91msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '99232'
      240μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 99232
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '99232'
      4.37msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 99232
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '99232' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      610μsalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 99232
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      210μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      440μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 59 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      25.22msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 59 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      9.83msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 59 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      8.01msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 99232 limit 1
      210μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 99232
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 99232 and content_type = 'article' order by status desc limit 1
      270μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid article_nid,a.title article_title,j.title journal_title from content_by_diseases cd inner join article a on a.article_id=cd.content_id inner join journal j on j.journal_id=a.journal_id where cd.pid = 283 and cd.sub_disease_id = 591 and content_id!=99232 and cd.content_type = 'article' order by rand() limit 20
      58.93msalphaeurekaselec_live_10_06_2022Article.php#769
      Backtrace
      • 11. app/Models/Article.php:769
      • 12. app/Http/Controllers/ArticleController.php:2098
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 173015 limit 1
      210μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 173015
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      200μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'EMIDDT' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      300μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: EMIDDT
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '99232' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      360μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '25' and is_uploaded = 1 and issue_id = 9522 order by cast(first_page as SIGNED) desc limit 1
      480μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 25
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '38' and is_uploaded = 1 and issue_id = 9522 order by cast(first_page as SIGNED) asc limit 1
      460μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 38
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      220μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      270μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 99232 limit 1
      3.89msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 99232
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 59 and `b`.`banner_from_date` <= 1739847366 and `b`.`banner_to_date` >= 1739847366 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.56msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 59
      • 3: 1739847366
      • 4: 1739847366
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 59 and `b`.`banner_from_date` <= 1739847366 and `b`.`banner_to_date` >= 1739847366 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.53msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 59
      • 3: 1739847366
      • 4: 1739847366
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='f6c7cccc79113b5b920d049f5af7925b'
      250μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        hEmHsDXTdgdoaeErd8asyJYFXeE3T66OOfl45nc3
        uc_cart_id
        f6c7cccc79113b5b920d049f5af7925b
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/99232" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/99232
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:9 [ "cookie" => array:1 [ 0 => "wayfindertarget=eyJpdiI6InRDVnlrQndXOWVhQS94M2MyMkppQXc9PSIsInZhbHVlIjoiYmFGUjcxTjNwT1ExWElHS2R0V1JCSG0vNG54ZDg3clRzZTlVcWo2cmxxbz0iLCJtYWMiOiI3MDY1NjU3Mzg5ZThiZTlhNzU3MWVmNTQzODZlM2M5MThmMDk3ZGZjNjMwMTkyNGRiNTk3N2E3Y2NkOTU1M2MzIiwidGFnIjoiIn0%3Dwayfindertarget=eyJpdiI6InRDVnlrQndXOWVhQS94M2MyMkppQXc9PSIsInZhbHVlIjoiYmFGUjcxTjNwT1ExWElHS2R0V1JCSG0vNG54ZDg3clRzZTlVcWo2cmxxbz0iLCJtYWMiOiI3MDY1NjU3Mzg5ZThi" ] "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        0 of 0
        array:1 [ "wayfindertarget" => null ]
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 18 Feb 2025 02:56:06 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFmcUtnQ1Y1MzhDbzNkVWlNbnZ4eUE9PSIsInZhbHVlIjoiQ2xFekY4N2FlWllxcDRydXJXQThzbzB3bUVwQmMwZ3B2M21aam9lMGV4OUpISHhaV1pTRHQ2ZU5sZi96VVNFZGpWTTBRNDV6TnI4ZHlLdkxPeGJ2dmlCb2RXVkM1b0ZTQm1aSWpQRzdHVDdGUFFaMDZSWUZvcFgwNzM1cW1lTTMiLCJtYWMiOiIyYmVjMjk3MDU2YzczZTQ0MWM4NzhkNjhmNmViMDMzMzUwNmQyNDQ5ODk3YzY4ODlhMDMwNDc0MGU0MjE1YzAzIiwidGFnIjoiIn0%3D; expires=Thu, 20 Feb 2025 14:56:06 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6IjFmcUtnQ1Y1MzhDbzNkVWlNbnZ4eUE9PSIsInZhbHVlIjoiQ2xFekY4N2FlWllxcDRydXJXQThzbzB3bUVwQmMwZ3B2M21aam9lMGV4OUpISHhaV1pTRHQ2ZU5sZi96VVNFZGpWTTBRN" 1 => "alphaeurekaselectnet_session=eyJpdiI6IkNORksreVRZdnZvN0kxVTI3SU56NGc9PSIsInZhbHVlIjoiV25scVVxeW9uSDFING83VGhkZjNKQzhUUFpYSjdaNTh0S0lLMTRsUjFWLzROL2wvRzhDaC93SlJkWUNDYUZZcWZXdTlwRS8yVTNVay9sVG0yTlYxcnR0ZVdQRGljTml5QUhjVGMzSEVpV3FBKzZKeUV0QlNwOTY3Wno0VTlOUEEiLCJtYWMiOiIzMDNhMzhhN2Y4M2FhNTY0MDAyNDE4YjBhNjA2Y2QwYTI4YWMyNmVmYWE5OWY1NWNhYWU0NTk5M2U4YzY3MjhiIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IkNORksreVRZdnZvN0kxVTI3SU56NGc9PSIsInZhbHVlIjoiV25scVVxeW9uSDFING83VGhkZjNKQzhUUFpYSjdaNTh0S0lLMTRsUjFWLzROL2wvRzhDaC93SlJ" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6IjFmcUtnQ1Y1MzhDbzNkVWlNbnZ4eUE9PSIsInZhbHVlIjoiQ2xFekY4N2FlWllxcDRydXJXQThzbzB3bUVwQmMwZ3B2M21aam9lMGV4OUpISHhaV1pTRHQ2ZU5sZi96VVNFZGpWTTBRNDV6TnI4ZHlLdkxPeGJ2dmlCb2RXVkM1b0ZTQm1aSWpQRzdHVDdGUFFaMDZSWUZvcFgwNzM1cW1lTTMiLCJtYWMiOiIyYmVjMjk3MDU2YzczZTQ0MWM4NzhkNjhmNmViMDMzMzUwNmQyNDQ5ODk3YzY4ODlhMDMwNDc0MGU0MjE1YzAzIiwidGFnIjoiIn0%3D; expires=Thu, 20-Feb-2025 14:56:06 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6IjFmcUtnQ1Y1MzhDbzNkVWlNbnZ4eUE9PSIsInZhbHVlIjoiQ2xFekY4N2FlWllxcDRydXJXQThzbzB3bUVwQmMwZ3B2M21aam9lMGV4OUpISHhaV1pTRHQ2ZU5sZi96VVNFZGpWTTBRN" 1 => "alphaeurekaselectnet_session=eyJpdiI6IkNORksreVRZdnZvN0kxVTI3SU56NGc9PSIsInZhbHVlIjoiV25scVVxeW9uSDFING83VGhkZjNKQzhUUFpYSjdaNTh0S0lLMTRsUjFWLzROL2wvRzhDaC93SlJkWUNDYUZZcWZXdTlwRS8yVTNVay9sVG0yTlYxcnR0ZVdQRGljTml5QUhjVGMzSEVpV3FBKzZKeUV0QlNwOTY3Wno0VTlOUEEiLCJtYWMiOiIzMDNhMzhhN2Y4M2FhNTY0MDAyNDE4YjBhNjA2Y2QwYTI4YWMyNmVmYWE5OWY1NWNhYWU0NTk5M2U4YzY3MjhiIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IkNORksreVRZdnZvN0kxVTI3SU56NGc9PSIsInZhbHVlIjoiV25scVVxeW9uSDFING83VGhkZjNKQzhUUFpYSjdaNTh0S0lLMTRsUjFWLzROL2wvRzhDaC93SlJ" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "hEmHsDXTdgdoaeErd8asyJYFXeE3T66OOfl45nc3" "uc_cart_id" => "f6c7cccc79113b5b920d049f5af7925b" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/99232" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-18 02:56:06GET/article/99232314321